Search

everythinglearnresearchcommunity

for

Search:↓

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

Scalp psoriasis features reversible hair loss and specific immune activation, with no significant hair follicle damage.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

Wnt/beta-catenin signaling in the skin helps fat cell development during hair growth and repair.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

The document concludes that doctors should recognize congenital triangular alopecia to avoid unnecessary treatments, as it does not respond to steroids like alopecia areata does.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.

The hydrogel patch helps heal diabetic wounds by releasing a healing agent in response to harmful molecules and improving skin regeneration.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

Skin organoids with NCSTN mutation show changes in hair follicle development and higher inflammation, key features of Hidradenitis Suppurativa.

Cholecystokinin may help reduce skin inflammation in psoriasis.

Epiduo® is an effective first-line acne treatment that reduces inflammation and combats antibiotic resistance.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Vitamin B5 and coenzyme A may help regulate the immune system and could improve treatments for chronic diseases and cancer.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Ulcerative colitis can cause skin issues due to immune system problems.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

STAT3 signaling is important for healthy skin and hair follicles, and its disruption can lead to skin conditions like atopic dermatitis.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

A man developed myasthenia gravis after alopecia areata, and treatment improved his symptoms and stopped hair loss.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.